Akela Pharma, Inc. Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Austin TX United States (1979)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2008
NCT00822614
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

fentanyl (Innovar) (1 trial)

Drugs in Phase 2 Trials (1)

Key: Akela Pharma, Inc. (0) Acquired (1)

sgn-00101 (1 trial)

Drugs in Phase 1 Trials (2)

Key: Akela Pharma, Inc. (0) Acquired (2)

poly-iclc (1 trial)

Verpasep (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cancer Pain (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4